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Abstract
The effects of cinnamaldehyde (CINN) on in vitro parameters of immunity and in vivo protection against avian coccidiosis were evaluated.
In vitro stimulation of chicken spleen lymphocytes with CINN (25–400 ng/ml) induced greater cell proliferation compared with the
medium control (P,0·001). CINN activated cultured macrophages to produce higher levels of NO at 1·2–5·0mg/ml (P,0·001), inhibited
the growth of chicken tumour cells at 0·6–2·5mg/ml (P,0·001) and reduced the viability of Eimeria tenella parasites at 10 and 100mg/ml
(P,0·05 and P,0·001, respectively), compared with media controls. In chickens fed a diet supplemented with CINN at 14·4 mg/kg, the
levels of IL-1b, IL-6, IL-15 and interferon-g transcripts in intestinal lymphocytes were 2- to 47-fold higher (P,0·001) compared with chick-
ens given a non-supplemented diet. To determine the effect of CINN diets on avian coccidiosis, chickens were fed diets supplemented with
CINN at 14·4 mg/kg (E. maxima or E. tenella) or 125 mg/kg (E. acervulina) from hatch for 24 d, and orally infected with 2·0 £ 104 sporu-
lated oocysts at age 14 d. CINN-fed chickens showed 16·5 and 41·6 % increased body-weight gains between 0–9 d post-infection (DPI) with
E. acervulina or E. maxima, reduced E. acervulina oocyst shedding between 5–9 DPI and increased E. tenella-stimulated parasite anti-
body responses at 9 DPI compared with controls.
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Coccidiosis, an intestinal disease caused by several species of
Eimeria protozoa, is an economically important disease for
commercial poultry production(1). Widespread use of anti-
biotic-based growth promoters has improved the efficiency
of worldwide poultry production. However, due to the emer-
gence of drug-resistant pathogens and the European Union’s
ban on the use of antibiotics as growth promoters in feeds,
interest has shifted toward the development of alternative
strategies, such as dietary supplementation with phytogenics,
to control avian coccidiosis(2). Phytogenics are a group of
natural growth promoters derived from herbs, spices or
other plants. In this regard, many medicinal foods and
herbal products are highly effective in enhancing host defence
against microbial infections, reducing tumorigenesis and
decreasing oxidative stress(3–6). Previous studies in our labora-
tory have demonstrated that chickens fed a diet supplemented
with phytogenics and subsequently challenged with Eimeria
parasites showed reduced gut lesions, enhanced body-
weight gain and decreased excreta oocyst output compared
with birds fed a control diet(7,8). Furthermore, altered
expression of immune-related genes in chickens was observed
after the feeding of phytogenics, supporting their well-known
medicinal effects(9,10). Therefore, it has been proposed that
phytogenics augment host immunity against infectious
agents through their ability to alter gene expression(7,8).
Cinnamaldehyde (CINN) is a constituent of cinnamon
(Cinnamomum cassia Presl (Lauraceae)) that is widely used
as a flavoring compound and has been traditionally used to
treat human diseases, including dyspepsia, gastritis and
inflammatory diseases. CINN has been reported to possess
antioxidant, antimicrobial and larvicidal activities(11–13), as
well as to modulate T cell differentiation(14). CINN has been
found to be active against human liver, lung and leukaemia
cancer cells in anticancer studies(15–17), is the most potent
antiproliferative constituent of C. cassia (18), and its antitumour
effects have also been described using a murine A375 model
of human melanoma(19).
*Corresponding author: Dr Hyun S. Lillehoj, fax þ1 301 504 5103, email Hyun.Lillehoj@ars.usda.gov
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At the physiological level, CINN protects the intestinal
microvilli, which are responsible for the absorption of nutri-
ents(20–22). Dietary feeding of CINN along with carvacrol
and capsaicin, or capsicum, improved feed conversion, but
did not improve body-weight gain compared with that of con-
trol chickens(23–25). While the mechanisms that are respon-
sible for these phenomena are unknown, it has been
suggested that they may involve morphological modification
of gastrointestinal mucosal cells(9) and/or altered expression
of metabolism-related genes(26). Chickens fed a diet sup-
plemented with CINN also displayed reduced intestinal colo-
nisation by Escherichia coli, Clostridium perfringens and
fungi, and increased colonisation by Lactobacillus spp., com-
pared with controls(23). Our previous microarray study
showed that feeding of CINN to chickens altered the
expression of sixty-two genes (thirty-one up-regulated,
thirty-one down-regulated) in intestinal intra-epithelial lym-
phocytes(26). Therefore, the present investigation was per-
formed to evaluate the effects of CINN on in vitro
parameters of immunity and to assess its ability to reduce
infection against avian coccidiosis in vivo.
Methods
Spleen lymphocyte proliferation
All experiments were approved by the Agricultural Research
Service Institutional Animal Care and Use Committee. Specific
pathogen-free Ross/Ross broiler chickens, aged 3 weeks
(Longenecker’s Hatchery, Elizabethtown, PA, USA), were
euthanised by cervical dislocation. Spleens were then
removed and placed in Petri dishes with 10 ml of Hanks’
balanced salt solution supplemented with penicillin (100 U/ml)
and streptomycin (100mg/ml) (Sigma, St Louis, MO, USA).
Cell suspensions were prepared by gently flushing through a
cell strainer and lymphocytes were purified by density gradient
centrifugation through Histopaque-1077 (Sigma)(4). The cells
were adjusted to 1·0 £ 107 cells/ml in Roswell Park Memorial
Institute (RPMI) 1640 medium without phenol red (Sigma) sup-
plemented with 10 % fetal bovine serum, penicillin (100 U/ml)
and streptomycin (100mg/ml), and 100ml/well were added
to ninety-six-well flat-bottomed plates containing CINN at
100ml/well (400, 100, 50 or 25ng/ml) from Pancosma S.A.
(Geneva, Switzerland), concanavalin A (500 ng/ml; Sigma) as
a positive control, or medium alone as a negative control. The
cells were incubated at 418C in a humidified incubator (Forma,
Marietta, OH, USA) with 5 % CO2 for 48 h and cell numbers were
measured using 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophe-
nyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt
(WST-8; Dojindo Molecular Technologies, Gaithersburg, MD,
USA) at 450 nm using a microplate spectrophotometer
(BioRad, Hercules, CA, USA).
Nitric oxide production by macrophages
HD11 chicken macrophages were cultured at 1·0 £ 106
cells/ml (100ml/well) in ninety-six-well plates with CINN at
100ml/well (1·2, 2·5 or 5·0mg/ml), recombinant interferon
(IFN)-g(27) (1·0mg/ml) as a positive control, or medium
alone as a negative control at 418C and 5 % CO2 for 24 h.
Cell culture supernatant fractions (100ml) were mixed with
100ml of Griess reagent (Sigma), incubated for 15 min at
room temperature, optical densities at 540 nm were measured
using a microplate spectrophotometer, and nitrite concen-
trations were determined using a standard curve generated
with known concentrations of sodium nitrite.
Tumour cell cytotoxicity
Retrovirus-transformed chicken RP9 B cells(4) were cultured at
1·0 £ 106 cells/ml (100ml/well) in ninety-six-well plates with
CINN at 100ml/well (0·3, 0·6, 1·2 or 2·5mg/ml), recombinant
chicken NK-lysin (1·0mg/ml) as a positive control, or
medium alone as a negative control at 418C and 5 % CO2 for
48 h, and cell numbers using 2-(2-methoxy-4-nitrophenyl)-
3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, mono-
sodium salt (WST-8) were measured at 450 nm using a
microplate spectrophotometer.
Parasite cytotoxicity
Freshly sporulated E. tenella oocysts were disrupted with
0·5 mm glass beads for 5–7 s and the freed sporocysts were
incubated in PBS containing 0·014 M-taurodeoxycholic acid
and 0·25 % trypsin to release sporozoites at 418C for 45 min.
Sporozoites were filtered, washed three times with RPMI
1640 at 2100 rpm at 48C for 10 min, incubated at 1 £ 106/ml
with 100 or 10mg CINN per ml at 418C for 24 h, and viability
was measured by trypan blue exclusion.
Quantification of intestinal cytokine mRNA levels
Chickens, aged 1 d (four birds per group), were housed at
298C in Petersime brooder units and were fed ad libitum
with a control diet (US Department of Agriculture Feed Mill,
Beltsville, MD, USA) or the control diet supplemented with
CINN at 14·4 mg/kg. This concentration of CINN was chosen
based upon pilot studies of cytokine mRNA levels. The control
diet contained 24·2 % crude protein, 4·7 % fat, 2·4 % fibre, 1·3 %
linoleic acid, 1 % Ca, 0·4 % available P, 0·8 % K, 1·5 % arginine,
1·2 % lysine and 0·8 % methionine þ cystine. At 14 d post-
hatch, the birds were euthanised by cervical dislocation.
Their intestinal tissues were removed, cut longitudinally and
washed three times with ice-cold Hanks’ balanced salt solution
containing penicillin (100 U/ml) and streptomycin (100mg/ml)
(Sigma). The mucosal layer was carefully removed using a sur-
gical scalpel and total RNA was extracted using TRIzol (Invi-
trogen, Carlsbad, CA, USA). Then 5mg of total RNA were
treated with 1·0 U of DNase I and 1·0ml of 10X reaction
buffer (Sigma), incubated at room temperature for 15 min,
1·0ml of stop solution was added to inactivate DNase I, and
the mixture was heated at 708C for 10 min. RNA was reverse-
transcribed using the StrataScript first-strand synthesis system
(Stratagene, La Jolla, CA, USA) according to the manufacturer’s
recommendations. Quantitative RT-PCR oligonucleotide
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primers for chicken IL-1b, IL-6, IL-15 and IFN-g and the
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
internal control are listed in Table 1. Amplification and detec-
tion were carried out using equivalent amounts of total RNA
using the Mx3000P system and Brilliant SYBR Green qPCR
master mix (Stratagene). Standard curves were generated
using log10 diluted standard RNA and the levels of individual
transcripts were normalised to those of GAPDH by the
QGene program(28). Each sample was analysed in triplicate.
To normalise individual replicates, the logarithmic-scaled
threshold cycle (Ct) values were transformed to linear units
of normalised expression before calculating means and SEM
for the references and individual targets, followed by the
determination of mean normalised expression using the
QGene program(28).
Experimental animals, diets and Eimeria infection
The immunomodulatory effect of CINN against avian
coccidiosis was evaluated in chickens infected with E. tenella,
E. acervulina or E. maxima. Briefly, chickens aged 1 d (twenty
per group) were fed with a control diet or a diet sup-
plemented with CINN at 14·4 or 125 mg/kg (the concentrations
in diets). These concentrations of CINN were chosen based
upon pilot studies of the immunomodulatory effect of
CINN on Eimeria-infected birds. At 14 d post-hatch, the birds
were transferred to cages (two birds per cage) for excreta
collection and were either uninfected or orally infected with
2·0 £ 104 sporulated oocysts of E. tenella, E. maxima or
E. acervulina as described(29). Body-weight gains were calcu-
lated between 0 and 9 d post-infection. For determination of
excreta oocyst shedding, birds were placed in cages (two
birds per cage, twelve per group) and the excreta samples
were collected daily between 5 and 9 d post-infection and
then pooled. Oocyst numbers per bird over 4 d were
calculated as described(30) using a McMaster chamber accord-
ing to the formula: total oocysts/bird ¼ (oocyst count £
dilution factor £ (excreta sample volume/counting chamber
volume))/2.
Serum antibody levels
Blood was obtained by cardiac puncture (four birds per
group) following euthanasia at 9 d post-infection and sera
were collected by centrifugation. Diluted sera (1:100, 100ml/
well) were added to ninety-six-well microtitre plates pre-
coated with 10mg per well of EtMIC2, a purified recombinant
microneme protein from E. tenella, as described(31), incubated
with agitation at room temperature for 1 h, and washed with
PBS containing 0·05 % Tween 20. Bound antibody was reacted
with peroxidase-conjugated rabbit anti-chicken IgG (Sigma)
and 3,30,5,50-tetramethylbenzidine substrate (Sigma), and opti-
cal density at 450 nm was determined using a microplate
spectrophotometer.
Statistical analyses
Each sample was analysed in triplicate or quadruplicate. Stat-
istical analyses were performed using SPSS software (SPSS
15.0 for Windows; SPSS, Inc., Chicago, IL, USA), and all data
were expressed as mean values with their standard errors.
Comparisons of the mean values were performed by
one-way ANOVA, followed by Student’s t test or Duncan’s
multiple-range test, and differences were considered statisti-
cally significant at P,0·05.
Results
Effects of cinnamaldehyde on in vitro and in vivo
parameters of immunity
Dietary CINN increased splenocyte proliferation at all concen-
trations tested compared with the medium control (P,0·001)
(Fig. 1(A)). Cell proliferation with CINN at 400 ng/ml was com-
parable with that of the concanavalin A-stimulated positive
control. NO levels in the cell culture media of CINN-treated
HD11 macrophages were greater than those of cells treated
with medium alone (P,0·001) (Fig. 1(B)). CINN had no
observable toxic effects on spleen cells or macrophages at
any of the concentrations tested. Treatment of RP9 tumour
Table 1. Oligonucleotide primers used for quantitative RT-PCR of chicken cytokines
RNA target Primer sequences
PCR product
size (bp)
Accession
no.
GAPDH
Forward
Reverse
50-GGTGGTGCTAAGCGTGTTAT-30
50-ACCTCTGTCATCTCTCCACA-30
264 K01458
IL-1b
Forward
Reverse
50-TGGGCATCAAGGGCTACA-30
50-TCGGGTTGGTTGGTGATG-30
244 Y15006
IL-6
Forward
Reverse
50-CAAGGTGACGGAGGAGGAC-30
50-TGGCGAGGAGGGATTTCT-30
254 AJ309540
IL-15
Forward
Reverse
50-TCTGTTCTTCTGTTCTGAGTGATG-30
50-AGTGATTTGCTTCTGTCTTTGGTA-30
243 AF139097
IFN-g
Forward
Reverse
50-AGCTGACGGTGGACCTATTATT-30
50-GGCTTTGCGCTGGATTC-30
259 Y07922
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IFN, interferon.
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cells with CINN at 0·6, 1·2 or 2·5mg/ml reduced cell viability
compared with the medium control (P,0·001) (Fig. 1(C)).
CINN decreased E. tenella sporozoite viability at 10mg/ml
(P,0·05) and 100mg/ml (P,0·001) compared with the
medium control (Fig. 1(D)). Finally, the levels of transcripts
encoding the pro-inflammatory cytokines IL-1b and IL-6,
as well as the Th1-type cytokines IL-15 and IFN-g, were
increased in the intestine of chickens fed CINN at
14·4 mg/kg by 12, 2·0, 10 and 47-fold, respectively, compared
with each of the non-supplemented control groups (P,0·001)
(Fig. 2).
Effect of cinnamaldehyde on in vivo protection against
avian coccidiosis
Chickens that were fed CINN at 125 mg/kg and infected with
E. acervulina, or were fed CINN at 14·4 mg/kg and infected
with E. maxima, had significantly (P,0·05) increased body-
weight gains between 0 and 9 d post-infection compared
with infected birds given a non-supplemented diet (Fig. 3(A)
and (B)). By contrast, feeding of CINN at 14·4 mg/kg had no
effect on body-weight gain of E. tenella-infected animals
(Fig. 3(C)).
Excreta oocyst number was reduced by 41 % in
E. acervulina-infected chickens fed with CINN at 125 mg/kg
compared with infected animals given the non-supplemented
diet (P,0·01) (Fig. 4). By contrast, excreta oocyst numbers of
E. maxima- or E. tenella-infected chickens given non-
supplemented or CINN-supplemented (14·4 mg/kg) diets
were equal. Finally, the levels of serum antibodies reactive
with the recombinant EtMIC2 protein were increased by 98 %
in E. tenella-infected chickens fed the CINN-supplemented diet
(P,0·001), but not in the birds given the CINN diet and
infected with E. acervulina or E. maxima, when compared
with animals on the control diet (Fig. 5).
Discussion
The present study demonstrated that CINN enhanced in vitro
and in vivo parameters of immunity and reduced experimental
Eimeria infection in vivo. It should be noted, however, that
these effects were Eimeria species specific and were not
detected across all observations. Treatment of chicken
spleen cells or HD11 macrophages with CINN increased pro-
liferation and NO production, respectively, and treatment of
chicken RP9 tumour cells or E. tenella sporozoites with
CINN decreased cell viability. For the in vivo studies, feeding
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Fig. 1. Effects of cinnamaldehyde (CINN) treatments on in vitro parameters of immunity. (A) Spleen cells were treated with the indicated concentrations of CINN,
concanavalin A (Con A) (500 ng/ml) or medium (control; Cont) for 48 h and viable cell numbers were measured using 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophe-
nyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8). (B) HD11 macrophages were treated with the indicated concentrations of CINN, recombinant
chicken interferon (IFN)-g (1·0mg/ml) or medium (Cont) for 24 h and NO levels were measured using Griess reagent. (C) RP9 tumour cells were treated with the
indicated concentrations of CINN, chicken NK-lysin (NKL; 1·0mg/ml) or medium (Cont) for 48 h and viable cell numbers were measured using WST-8. (D) Eimeria
tenella sporozoites were treated with the indicated concentrations of CINN or medium (Cont) for 24 h and viability was assessed by trypan blue exclusion.
OD, optical density at 450 or 540 nm. Values are means (n 4), with standard errors represented by vertical bars. Mean value was significantly different from that of
the medium-treated (Cont) group: * P,0·05, *** P,0·001 (Student’s t test).
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of CINN increased the levels of intestinal mRNA encoding
IL-1b, IL-6, IL-15 and IFN-g, reduced E. acervulina- and
E. maxima-induced body-weight loss, reduced E. acervulina
oocyst shedding, and increased the E. tenella-stimulated
EtMIC2 antibody response compared with feeding of the
control diet.
Previous studies have demonstrated the beneficial effects
of plant extracts in chicken diets for reducing the number
of pathogenic gut bacteria without increasing digestibility of
nutrients (crude protein, fibre and amino acids), and reducing
body-weight loss due to Eimeria infection(23,32). The results of
the present study revealed that CINN-fed birds showed
increased body-weight gain after E. acervulina or E. maxima
infection and decreased oocyst shedding following
E. acervulina infection compared with controls. The signifi-
cant effect of CINN on body-weight gain and oocyst reduction
in the E. acervulina-infected animals compared with the
E. maxima- and E. tenella-infected groups may have been
due to the relatively higher concentration of the phytogenic
in the diet fed to E. acervulina birds (125 v. 14·4 mg/kg).
However, when compared with the previous concentrations
of dietary supplement used in coccidiosis control (ranging
from 200 to 1000 mg/kg)(8,29,31), the concentration used in
the present study (125 mg/kg) was relatively low. In addition,
given that the challenge dose of Eimeria parasites used in the
present investigation (2·0 £ 104 oocysts per bird) is likely to be
considerably higher than the exposure level in commercial
production flocks, it remains to be determined whether the
lower CINN supplementation also may provide protection
against coccidiosis in poultry raised under normal field con-
ditions. It is interesting to note, however, that chickens
provided with the higher dose of CINN and infected with
E. acervulina nevertheless failed to generate antibodies that
cross-reacted with EtMIC2.
T and B lymphocytes, macrophages, monocytes and natural
killer cells mediate innate and acquired immune defences.
Macrophages play an important role in host defence against
infectious agents and tumours, in part, through the production
of effector molecules, such as NO, and IFN-g-stimulated NO
production by chicken macrophages has been reported(33).
Previous studies have demonstrated that the effects of plant
extracts on host defence against microbial pathogens and
tumours directly correlated with increased cell-mediated
immunity(4,5,8). The present results demonstrating a stimu-
latory effect of CINN on in vitro NO production in chicken
macrophages may be related to the result of the in vivo
study in which CINN increased IFN-g expression in the intes-
tine. Moreover, the present data correlate well with previous
reports that documented the bioactive properties of
medicinal foods and herbs on macrophage activation(6,34,35).
On the other hand, other studies have reported that CINN
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Fig. 2. Effects of a cinnamaldehyde (CINN)-supplemented diet on intestinal cytokine transcript levels. Chickens were fed a non-supplemented diet (control; Cont)
or a diet supplemented with CINN at 14·4 mg/kg. At 14 d post-hatch, intestinal tissue was removed and the levels of transcripts for IL-1b (A), IL-6 (B), IL-15
(C) and interferon (IFN)-g (D) were quantified by real-time RT-PCR. GAPDH, glyceraldehyde 3-phosphate dehydrogenase. Values are means (n 12), with
standard errors represented by vertical bars. *** Mean value was significantly different from that of the group fed the non-supplemented diet (Cont) (P,0·001;
Student’s t test).
S. H. Lee et al.866
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114511001073
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 10 Jul 2017 at 15:38:27, subject to the Cambridge Core terms of use, available at
suppressed NO production by lipopolysaccharide-activated
mouse macrophages(36).
Protective immunity to Eimeria infection is accompanied by
the production of a collection of cytokines, chemokines and
other protein mediators of local inflammatory responses(1).
For example, IL-1b is a pro-inflammatory cytokine that is
produced by macrophages, monocytes, and dendritic cells
that play a central role in the regulation of immune and
inflammatory responses. In mammals, IL-1b increases the
expression of cell adhesion molecules on endothelial cells to
enable the transmigration of blood leucocytes to extravascular
sites of infection(37). In chickens, IL-1b given simultaneously
with a DNA vaccine following oral Eimeria infection exerted
an adjuvant effect by reducing excreted oocyst shedding(38).
IL-6 is produced by T cells and macrophages and acts as
both a pro-inflammatory and an anti-inflammatory cytokine,
depending upon the context of its expression, whereas IL-15
is primarily secreted by mononuclear phagocytes and
enhances the activation of memory T cells(39). Chicken IL-15
promoted the survival of T lymphocytes and natural killer
cells and enhanced protective immunity to experimental coc-
cidiosis when co-administered with a DNA vaccine(38,40). IFN-
g is a common marker of cellular immunity and high levels of
IFN-g are associated with protective immune responses to
coccidiosis(29). Administration of recombinant IFN-g to chick-
ens increased resistance against coccidiosis, significantly
reduced the intracellular development of Eimeria parasites(27),
and showed an adjuvant effect when given with a DNA vac-
cine(41). On the basis of these reports, we predict that
enhanced production of these cytokines in birds that are con-
tinuously fed with a diet supplemented with CINN at a rela-
tively low concentration may provide a novel opportunity to
increase anti-coccidial immunity and reduce parasite
fecundity.
In conclusion, the present results provide the first demon-
stration that, in general, dietary CINN enhances in vitro par-
ameters of immunity and reduces Eimeria infection of
chickens. While these effects were Eimeria species specific
and were not observed across all experiments, the following
key observations were reproducibly validated: dietary CINN
attenuated E. acervulina and E. maxima-induced body-
weight loss, decreased E. acervulina oocyst shedding, and
increased E. tenella-stimulated EtMIC2 antibody responses
compared with the non-supplemented control diet. Further
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Fig. 4. Effect of cinnamaldehyde (CINN)-supplemented diets on excreta
oocyst shedding following Eimeria infection. Chickens were fed a non-
supplemented diet (control; Cont) or diets supplemented with CINN at 125 or
14·4 mg/kg. At 14 d post-hatch, chickens were orally infected with 2·0 £ 104
sporulated oocysts of Eimeria acervulina (125 mg CINN/kg), E. maxima
(14·4 mg CINN/kg) or E. tenella (14·4 mg CINN/kg) and excreta oocyst
numbers were measured between 5 and 9 d post-infection. Values are
means (n 12), with standard errors represented by vertical bars. ** Mean value
was significantly different from that of the group fed the non-supplemented
diet (Cont) (P,0·01; Student’s t test).
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Fig. 3. Effect of cinnamaldehyde (CINN)-supplemented diets on body-weight
gain following Eimeria infection. Chickens were fed a non-supplemented
diet (control; Cont) or diets supplemented with CINN at 125 mg/kg (A) or
14·4 mg/kg (B, C). At 14 d post-hatch, chickens were uninfected or
orally infected with 2·0 £ 104 sporulated oocysts of Eimeria acervulina (A),
E. maxima (B) or E. tenella (C) and body-weight gains were measured
between 0 and 9 d post-infection. Values are means (n 20), with standard
errors represented by vertical bars. a,b,c Mean values with unlike letters were
significantly different (P,0·05; Duncan’s multiple-range test). The improve-
ment in body-weight gain of birds fed the CINN-supplemented diet com-
pared with those fed the non-supplemented diet following infection with
E. acervulina was 16·5 % (A). The improvement in body-weight gain of birds fed
the CINN-supplemented diet compared with those fed the non-supplemented
diet following infection with E. maxima was 41·6 % (B).
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studies are necessary to better understand the underlying
immune mechanisms that are responsible for these effects
and to assess the ability of dietary CINN to provide a safe
and effective alternative disease control method against
avian coccidiosis in commercial production facilities.
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